3rd Quarter - Report

SQUIRE PATTON BOGGS for RANBAXY INC.

Firm
Client
Income
$160,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 369/H.R. 1706, Preserve Access to Affordable Generics; H.R. 759, FDA Globalization Act; S. 3690, Drug Safety and Accountability Act; Implementation of P.L. 111-148, Patient Protection and Affordable Care; Implementation of P.L. 111-152, Health Care and Education Reconciliation

Foreign entity interest: Ranbaxy Labs Limited; interests are same as registrant.

LobbyistCovered position, as disclosed
JOHN JONAS —
ERIC RASMUSSEN SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000
MATTHEW TODD TUTEN RepMichaelBilirakis91-92;93-95;98-01
ANURAG VARMA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3690 (111th), S. 369 (111th), H.R. 759 (111th), H.R. 1706 (111th)

Pharmacy PHA

S. 369/H.R. 1706, Preserve Access to Affordable Generics; H.R. 759, FDA Globalization Act; S. 3690, Drug Safety and Accountability Act; Implementation of P.L. 111-148, Patient Protection and Affordable Care; Implementation of P.L. 111-152, Health Care and Education Reconciliation

Foreign entity interest: Ranbaxy Labs Limited - Interests are same as Registrant.

LobbyistCovered position, as disclosed
JOHN JONAS —
ERIC RASMUSSEN SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000
MATTHEW TODD TUTEN RepMichaelBilirakis91-92;93-95;98-01
ANURAG VARMA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3690 (111th), S. 369 (111th), H.R. 759 (111th), H.R. 1706 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.